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munoprecipitated with EGFP-mPar3 but not EGFP
alone.
To test whether mPar3 associates with APC and
KIF3A in vivo, we performed immunoprecipitation exper-
iment with rat brain lysate prepared from embryonic 18
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(E18) rat embryos. Indeed, APC and KIF3A were de-1550 4th Street
tected in the immunoprecipitate isolated with anti-San Francisco, CA 94143-0725
mPar3 antibody but not in control when no primary anti-
body was included (Figure 1A, left panel). Conversely,
mPar3 and KIF3A were coimmunoprecipitated with anti-
Summary APC antibody (Figure 1A, right panel). Thus, mPar3,
APC, and KIF3A form a complex in vivo in the developing
In developing hippocampal neurons in culture, the rat brain.
evolutionarily conserved polarity complex mPar3/
mPar6/aPKC selectively accumulates at the tip of one, APC Becomes Spatially Polarized in Developing
and only one, of the immature neurites of a neuron Hippocampal Neurons
and thus specifies the axon and generates neuronal To see whether APC mediates mPar3 polarization, we
polarity [1–3]. How mPar3/mPar6 is enriched at the tip first examined the distribution of APC in developing hip-
of the nascent axon, but not the dendrites, is not fully pocampal neurons in culture. Neurons were double la-
understood. Here, we report that mPar3 forms a com- beled with anti-APC antibody and anti-TUJ1 antibody,
which recognizes the neuronal-specific class IIIplex with adenomatous polyposis coli (APC) and
-tubulin and, hence, explicitly labels neurons includingkinesin superfamily (KIF) 3A, proteins that move along
their processes but not glia. In stage 2 nonpolarizedmicrotubules. In polarizing hippocampal neurons, APC
neurons, APC was present not only in the cell bodyselectively accumulates at the nascent axon tip and
but also at the tips of multiple undifferentiated minorcolocalizes with mPar3. Expression of dominant-neg-
neurites (Figure 1B, left panel; percentage of neuronsative C terminus deletion mutants of APC or ectopic
with more than one neurite containing mPar3: 98 2%,expression of APC leads to dislocalization of mPar3
n  24, Figure 1C, gray bar). In contrast, in stage 3and defects in axon specification and neuronal polar-
polarized neurons, APC was selectively enriched at theity. In addition to spatial polarization of APC, the selec-
Tau1-positive nascent axon, particularly at its tip (Fig-tive inactivation of the GSK-3 activity at the nascent
ures 1B, right panel, and 1E), but not the MAP2-positiveaxon tip is required for mPar3 targeting and polariza-
dendrites labeled with the dendritic marker MAP2 (Fig-tion and establishing neuronal polarity. These results
ures 1B, right panel and 1D, percentage of neurons withsuggest that mPar3 is polarized in developing neurons
more than one neurites containing mPar3: 8  5%, n through APC- and kinesin-mediated transport to the
36; Figure 1C, gray bar). These results clearly showedplus ends of rapidly growing microtubules at the na-
that, as neurons polarize, the APC protein becomes spa-scent axon tip, a process that involves a spatially regu-
tially polarized, accumulating at the tip of the rapidlylated GSK-3 activity.
growing nascent axons but not dendrites (average im-
munofluorescence intensity at the tip in arbitrary unit
(AU): axon, 82  7; dendrite, 15  2; n  19; p  0.001,Results and Discussion
Figure 1F). The dynamic redistribution of APC in polariz-
ing hippocampal neurons is reminiscent of what we pre-mPar3 Forms a Complex with APC
viously characterized for mPar3 [1], raising the intriguingand KIF3A In Vivo
possibility that APC, which associates with mPar3, isAs a developing hippocampal neuron polarizes from
involved in selectively targeting mPar3 to the tip of thestage 2 to stage 3, mPar3 becomes selectively enriched
nascent axon. Consistent with this possibility, APC colo-at the tip of one, and only one, neurite that is actively
calized with mPar3, particularly at the axonal tip (Figuresgrowing—the nascent axon but not the other neurites
1G and 1H). In addition, APC partially colocalized with[1–3]. To search for molecules that interact with mPar3
mPar3 along the shaft of the nascent axon in a punctateand potentially mediate its polarization, we first ex-
pattern (Figure 1H). These results suggest that mPar3pressed in COS-7 cells the full-length mPar3 fused with
is transported together with APC to the tip of the rapidlyEGFP at its N terminus, EGFP-mPar3, and performed
growing nascent axon. The diffuse staining of mPar3 inan immunoprecipitation assay with anti-EGFP antibody
the shaft, which did not colocalize with APC puncta,by using untransfected COS-7 cells or those expressing
might come from short splicing forms of mPar3.EGFP alone as control (Figure S1 in the Supplemental
Data available with this article online). Interestingly, two
APC Is Involved in mPar3 Proper Targetingproteins involved in microtubule-based directional pro-
and Polarization and Is Essential for Specifyingtein transport, APC and KIF3A, were specifically coim-
Axon and Neuronal Polarity
Having found that APC forms a complex with mPar3
and partially colocalizes with mPar3 in developing hip-*Correspondence: ynjan@itsa.ucsf.edu
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Figure 1. APC Forms a Complex with mPar3 and KIF3A In Vivo and Becomes Spatially Polarized in Developing Hippocampal Neurons
(A) Coimmunoprecipitation from E18 embryonic rat brain lysate. Lysate of the embryonic rat brain was incubated with either anti-APC antibody
(left) or anti-mPar3 antibody (right). The immunoprecipitates were analyzed by immunoblotting with the antibodies against mPar3, KIF3A and
APC as indicated. Immnoprecipitates with no primary antibody were used as control.
(B) Localization of APC in stage 2 nonpolarized (left) and stage 3 polarized (right) neurons. Neurons cultured in vitro were double-labeled with
antibodies against TUJ1 (green, left) and APC (red, middle). The overlay images are shown at the right. The scale bars represent 25 m and
50 m, respectively.
(C) The percentage of stage 2 and stage 3 neurons with APC in one (black) or more than one (gray) neurites.
(D and E) APC (red) is selectively enriched in the tip of the nascent axon, labeled with Tau1 (C, green), but not the dendrites, labeled with
MAP2 (D, green). Arrowheads indicate the tips of dendrites, and arrows indicate the tip of the nascent axon, where APC accumulates. The
scale bar represents 50 m.
(F) Quantification of APC immunofluorescence intensity at the tips of the nascent axon and the dendrites in stage 3 neurons (*p  0.001).
(G) Colocalization of APC (red) and mPar3 (green) at the tip of the nascent axon in a stage 3 polarized neuron. Arrows indicate the tip of the
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pocampal neurons, we next tested whether APC is re- 2G and 2H). These results suggest that APC is essential
for specifying axon and generating neuronal polarity,quired for the proper targeting and polarization of
mPar3. APC is a large protein with multiple protein inter- likely through regulating mPar3 polarization in devel-
oping hippocampal neurons.action domains. Over 60% of all somatic mutations in
APC reside within a relatively small region between co-
dons 1286 and 1513 [4]. These mutations almost always Ectopic Expression of APC Abolishes mPar3
Polarization and Neuronal Polarityresult in a C-terminal truncation that removes the bind-
ing sites for microtubules, EB1, DLG, and some of the Having found that APC is polarized in developing hippo-
campal neurons and that perturbation of its function withbinding sites for -catenin, GSK-3, and axin. Thus,
these truncated APC proteins often act in a dominant- dominant-negative truncation mutants prevents mPar3
polarization, we next tested whether abolishing the po-negative fashion [5, 6]. To examine the functional role
of APC on mPar3 polarization, we examined the effect larized distribution of APC will also prevent the mPar3
polarization and result in neuronal polarity defects. Toof two well-characterized, naturally occurring dominant-
negative C-terminal truncation mutants of APC [4, 6], address this, we ectopically expressed APC in devel-
oping hippocampal neurons by transfecting them withAPC(1–1388) and APC(1–900), on mPar3 distribution in
polarizing hippocampal neurons. In control neurons ex- APC together with EGFP, APC/EGFP. As predicted,
mPar3 failed to become spatially polarized in neuronspressing EGFP alone, mPar3 showed normal polariza-
tion and was selectively enriched at the tip of the nascent ectopically expressing APC, indicating that a polarized
distribution of APC is critical for mPar3 targeting andaxon (Figure 2A). By contrast, in neurons expressing
EGFP-APC(1-1388), mPar3 failed to become polarized polarization (Figure 3A). In some neurons transfected
with APC/EGFP, mPar3 was not effectively targeted to(Figure 2B). In fact, mPar3 was not effectively targeted
to the tips of the neurites; instead, it was retained in the the tips of neurites but retained in the cell body (Figure
3A, top), whereas in others, mPar3 was abundant at thecell body, leading to an elevated mPar3 immunofluores-
cence signal at the cell body when compared to nearby tips of two or more neurites (Figure 3A, bottom). This
difference might be due to the different expression leveluntransfected neurons (relative average mPar3 immuno-
fluorescence intensity at the cell body: EGFP, 96 17%, of APC and the developmental heterogeneity of culture
neurons being transfected. As expected from the defectn  6, p  0.7; EGFP-APC(1–1388), 154  18%; n  9;
p 0.005; Figure 2D). Similar results were obtained with in mPar3 localization, neurons transfected with APC/
EGFP were not properly polarized (percentage of neu-another dominant-negative truncation mutant of APC,
EGFP-APC(1–900) (relative average mPar3 immunofluo- rons polarized: 29  9%, n  71, p  0.001; Figure 3D).
Consistent with the existence of two patterns of mPar3rescence intensity at the cell body: 136  10%; n  11;
p  0.005; Figures 2C and 2D). These results suggest distribution, some neurons transfected with APC/EGFP
contained multiple short processes with no single prom-that APC is involved in targeting and polarization of
mPar3 in developing hippocampal neurons. inent long process (Figure 3B, top) that expressed the
axonal marker Tau1 (Figure 3C, top), whereas othersPreviously, we have shown that the polarization of
mPar3 is critical for specifying axon and generating neu- grew more than one prominent long processes (Figure
3B, bottom) that expressed the axonal marker Tau1 (Fig-ronal polarity [1]. If APC is involved in targeting and
polarization of mPar3, we should see defects in axon ure 3C, bottom). These results suggest that the spatially
polarized distribution of APC is important for specifyingspecification and neuronal polarity in neurons express-
ing dominant negative truncation mutants of APC. In- a single axon and establishing neuronal polarity. Inter-
estingly, ectopic expression of end binding protein (EB)deed, while most control neurons expressing EGFP
alone showed normal polarization with one and only 1 had no effect on neuronal polarity (data not shown).
one long process labeled with Tau1 and some short
processes labeled with MAP2 (percentage of neurons A Spatially Regulated GSK-3 Activity Is Required
for mPar3 Polarization and Axon Specificationpolarized, 86  3%, n  69; Figure S2), the majority
of neurons expressing the dominant-negative deletion Because APC has been found to associate with GSK-
3 [7, 8] and the binding of APC to microtubules ismutant EGFP-APC(1–1388) were without a single long
process; instead, they grew multiple neurites with similar regulated by GSK-3 activity [9], we asked whether
GSK-3 activity is important for mPar3 targeting and forlengths revealed by TUJ1 staining (percentage of neu-
rons polarized, 11  6%, n  28; p  0.001; Figure 2E). specifying axon and neuronal polarity. Whereas control
neurons treated with DMSO grew a prominent longThis defect in neuronal polarity was further confirmed
with Tau1 and MAP2 staining; these neurons were de- Tau1-positive axon and multiple short MAP2-positive
dendrites, inhibition of GSK-3 activity with two structur-void of a single long process that labeled with Tau1
(Figure 2F). Similar results were obtained with the domi- ally unrelated GSK-3-specific inhibitors, AR-A014418
[10] and LiCl [11, 12], caused neurons to be largelynant-negative mutant EGFP-APC(1-900) (percentage of
neurons polarized, 21  6%, n  32; p  0.001; Figures devoid of a long Tau1-positive axon; instead, most neu-
nascent axon where APC and mPar3 accumulate and colocalize, and arrowheads indicate the positions of dendrites. The transmitted light
image is shown to the right of immuofluorescence images. The scale bar represents 50 m.
(H) High-magnification images of the staining of APC and mPar3 in the nascent axon of a stage 3 neuron. Arrows indicate the colocalization
of APC puncta with mPar3 puncta, and arrowheads indicate the colocalization of APC and mPar3 at the tip of the axon. The scale bar
represents 5 m.
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Figure 2. APC Is Required for Proper Targeting of mPar3 in Developing Hippocampal Neurons and Specifying Axon and Neuronal Polarity
(A) Localization of mPar3 in neurons expressing EGFP alone. Neurons transfected with EGFP (green) 6–8 hr after plating and then cultured
for 48 hr were double labeled with antibodies against mPar3 (red) and TUJ1 (purple). The overlay image is shown at the right. Arrowheads
indicate the position of cell bodies of a neuron expressing EGFP and a nearby, untransfected neuron, and arrows indicate the tip of its long
axonal process where APC selectively accumulates. The same preparation, experimental procedure, and display convention are used in the
subsequent two panels. The scale bar represents 50 m.
(B and C) Localization of mPar3 in neurons expressing the dominant negative truncation mutants of APC, EGFP-APC(1-1388) (B) and EGFP-
APC(1-900) (C). Note that mPar3 is not effectively transported to the tips of the neurites in neurons tranfected with either EGFP-APC(1–1388)
or EGFP-APC(1–900). The scale bar represents 50 m.
(D) Quantification of relative mPar3 immunofluorescence intensity on average at cell body of neurons transfected (trans) with EGFP alone,
EGFP-APC(1–1388), and EGFP-APC(1–900) when compared to nearby untransfected (untrans) control neurons (*p0.05). Images of the cell
bodies of one pair of trans and untrans neurons are shown at the top. The scale bar represents 10 m.
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Figure 3. Ectopic Expression of APC Impairs mPar3 Polarization and Neuronal Polarity
(A) Localization of mPar3 in neurons transfected with APC together with EGFP. Neurons transfected with APC/EGFP (green) and then cultured
for 48 hr were double labeled with antibodies against mPar3 (red) and TUJ1 (purple). The overlay image is shown at the right. Arrowheads
indicate the positions of cell bodies of a neuron expressing APC/EGFP and a nearby untransfected control neuron. Arrows indicate the
accumulation of mPar3 at the tip of the long axonal process of a nearby untransfected neuron (top panels) and the accumulation of mPar3
at the tips of several processes of a APC/EGFP transfected neuron (bottom panels). The scale bar represents 50 m.
(B and C) Neurons ectopically expressing APC together with EGFP, APC/EGFP, show defects in neuronal polarity. Neurons transfected with
APC/EGFP (green) around 6–8 hr after plating and cultured for 48 hr were either labeled with neuronal specific marker TUJ1 (red) (B) or
double labeled with the axonal marker Tau1 (red) and the dendritic marker MAP2 (blue) (C). The overlay image is shown at the right. Note
that some neurons transfected with APC/EGFP lack a single long process that expresses the axonal marker Tau1 (top panels), whereas other
neurons transfected with APC/EGFP exhibit more than one long process that expresses the axonal marker Tau1 (bottom panels). The scale
bar represents 50 m.
(D) Quantification of polarity defect in neurons expressing APC/EGFP (*p0.001).
rons only contained multiple MAP2-labeled short pro- downstream target of PI 3-kinase [13]. Activation of
PKB/Akt by PI(3,4,5)P3, the lipid product of PI 3-kinase,cesses of similar lengths (DMSO, 76  9%, n  53; AR-
A014418, 17  5%, n  134, p  0.005; LiCl (0.5 mM), can lead to phosphorylation of GSK-3 at Ser9, thereby
inhibiting GSK-3 activity [14]. Given that PI 3-kinase78  3%, n  73, p  0.8; LiCl (5 mM), 26  7%, n 
71, p0.005; Figures 4A and S3), indicating that GSK-3 activity and its lipid product PI(3,4,5)P3 are necessary
and sufficient for specifying axons in developing hippo-activity is required for specifying axon and establishing
neuronal polarity. campal neurons [1, 3, 15], in which PI 3-kinase activity
is elevated preferentially at the tip of the nascent axon,How might GSK-3 activity be involved in specifying
axon and establishing neuronal polarity? GSK-3 is a we first asked whether GSK-3 activity is spatially regu-
(E and F) Neurons expressing the dominant-negative truncation mutant of APC, EGFP-APC(1-1388), show defects in neuronal polarity. Neurons
transfected with EGFP-APC(1388) around 6–8 hr and cultured for 48 hr were either labeled with TUJ1 (red, E) or double labeled with MAP2
(blue) and Tau1 (red, F). Note that neurons transfected with EGFP-APC(1–1388) lack a single prominent long process that expresses the
axonal marker Tau1. Instead, they contain several short MAP2-positive processes with similar lengths. The same preparation, experimental
procedure, and display convention are used in the subsequent two panels. The scale bars represent 25 m (top) and 50 m (bottom).
(G and H) Neurons expressing the dominant-negative truncation mutant of APC, EGFP-APC(1–900), show defects in neuronal polarity. The
scale bar represents 50 m.
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Figure 4. GSK-3 Activity Is Required for Proper Targeting of mPar3 and Establishing Neuronal Polarity
(A) Compared to neurons treated with DMSO (left), hippocampal neurons treated with either 20 M AR-A014418 (middle) or 5 mM LiCl (right),
two structurally unrelated inhibitors specific for GSK-3, do not contain a single long process that expresses the axonal marker Taul. Images
shown are representative of 3–5 independent experiments. The scale bar represents 100 m.
(B) Neurons treated with GSK-3 inhibitors show defect in mPar3 polarization. Neurons treated with either DMSO as control (top panels), 20
M AR-014418 (middle panels), or 5 mM LiCl (bottom panels) 6–8 hr after plating and then cultured for 48 hr were double labeled with
antibodies against the neuronal specific marker TUJ1 (green, left) and mPar3 (red, middle). The overlay is shown at the right. Arrows indicate
the tips of the nascent axons of control neurons treated with DMSO where mPar3 selectively accumulates. The scale bar represents 100 m.
lated accordingly. Indeed, we found that the phosphory- different between the tip of the nascent axon and those
of the dendrites (immunofluorescence intensity at thelated and, hence, inactive form of GSK-3 was more
abundant at the tip of the Tau1-positive nascent axon tip in AU: axon, 81  9; dendrite, 72  8; n  17; p 
0.6; Figure S4). Next, we tested whether this spatiallythan the tips of the dendrites (immunofluorescence in-
tensity at the tip in AU: axon, 178  11; dendrite, 41  regulated GSK-3 activity is involved in mPar3 polariza-
tion by examining mPar3 distribution in neurons treated5; n  9; p  0.001), whereas the total GSK-3 was not
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with either AR-A014418 or LiCl. Compared to neurons come the axon. In such polarizing neurons, we found
that APC selectively accumulates at the tip of the activetreated with DMSO as control, mPar3 in neurons treated
growing neurite—the nascent axon but not the otherwith these GSK-3 specific inhibitors was largely dislo-
neurites, thereby becoming spatially polarized in a man-calized, either ineffectively targeted to the tips of the
ner similar to that of mPar3. In fact, APC colocalizesprocesses or not spatially polarized (percentage of neu-
with mPar3 at the nascent axonal tip, suggesting thatrons with dislocalized mPar3: DMSO, 31  3%, n  26;
APC is involved in selectively targeting mPar3 to the tipAR-A014418, 88  4%, n  60, p  0.001; LiCl (5 mM),
of the actively growing nascent axon. Indeed, mPar387  4%, n  50, p  0.001; Figure 4B). These findings
fails to polarize in developing neurons that are eithersuggest that a spatially regulated GSK-3 activity, pos-
expressing the dominant-negative C-terminal truncationsibly due to spatially regulated PI 3-kinase activity, is
mutants of APC or ectopically expressing wild-type APCimportant for proper targeting of mPar3, thereby speci-
to obliterate its polarized distribution. Consequently,fying the axon and generating neuronal polarity.
these neurons were not polarized properly. Conceivably,In polarizing hippocampal neurons, mPar3 is selec-
the positive feedback due to APC accumulation at the tiptively enriched at the tip of the actively growing nascent
of the actively growing neurite and its ability to promoteaxon, but not the dendrites. This polarized distribution
microtubule assembly and bundling is one key elementof mPar3 is critical for axon specification and neuronal
in the specification of the nascent axon. These resultspolarity [1–3]. However, the molecular mechanism that
provide evidence for a new functional role of APC inunderlies the preferential localization of mPar3 to the
regulating the proper targeting of the polarity proteintip of the nascent axon is not known. In this study,
mPar3 in developing neurons, an essential process forwe have found that mPar3 forms a complex with the
specifying axon and establishing neuronal polarity.microtubule binding protein APC and the kinesin family
How might APC fit in the signaling pathway for neu-motor protein KIF3A in vivo. The association of mPar3
ronal polarization? APC can be phosphorylated by GSK-with APC and KIF3A points to the possibility that mPar3
3 [23]. Phosphorylation of APC by GSK-3 decreasesis polarized through directional protein transport medi-
its interaction with microtubules [9], which could in turnated by KIF3, the microtubule plus-end-directed motors,
regulate the targeting of APC and its associated proteinsin developing hippocampal neurons.
such as mPar3 and neuronal polarity. Recently, GSK-However, mPar3 is not simply transported to the tips
3 and APC are shown to be involved in NGF-inducedof neurites of polarizing hippocampal neurons. Rather,
axonal outgrowth [24]. However, their roles in axonthe spatially polarized distribution of mPar3 indicates
specification and neuronal polarity are not known. Hav-that it is selectively targeted to the tip of the actively
ing found that APC and its polarized distribution aregrowing nascent axon but not the dendrites. Microtu-
involved in mPar3 polarization and neuronal polarity, webules are uniformly oriented with their plus ends facing
also examined the potential involvement of GSK-3 inthe tips of all immature neurites, including those that
mPar3 polarization. Inhibition of GSK-3 activity in de-will become dendrites. Only after the axon is specified
veloping neurons leads to dislocalization of mPar3 anddo other neurites begin to exhibit microtubules with their
to defects in neuronal polarity, suggesting that GSK-3minus ends pointing to the tips [16]. So how is mPar3
activity is involved in mPar3 polarization and neuronalselectively transported to the tip of the nascent axon,
polarity. In fact, we found that GSK-3 activity is nonuni-given that microtubules in all the immature neurites are
form in polarizing neurons because the phosphorylatedorientated the same way? It is of interest to note here
and, hence, inactive form of GSK-3was more abundantthat APC is in association with mPar3 and KIF3A in
at the tip of the actively growing nascent axon whenthe embryonic rat brain and the polarizing hippocampal
compared to the dendritic tip. Taken together, our re-neurons in culture. APC is well known for its involvement
sults suggest that a spatially regulated GSK-3 activity,in Wnt signaling by mediating the degradation of-catenin
likely due to a spatially regulated PI 3-kinase activity [1,[8, 17]. However, there is growing evidence for yet an-
15], and a spatially localized APC are critical for mPar3other role of APC related to microtubule dynamics and
polarization and neuronal polarity. Interestingly, in mi-microtubule-based transport. APC binds to microtubules
grating astrocytes, GSK-3 and APC are suggested todirectly and stimulates microtubule assembly and bund-
act downstream of Par6 in controlling cell polarity [21].ling in vitro [18]. In epithelial cells, APC moves along micro-
It is worth noting that PI 3-kinase activity and Par3,tubules and accumulates in cortical clusters selectively
which are the essential components in specifying axonat the tips of actively extending membranes [19], in a
and neuronal polarity [1–3, 15], are not involved in con-
manner independent of the microtubule plus-end bind-
trolling migrating astrocyte polarity [21, 25]. These differ-
ing protein EB1 [20]. Similarly, in migrating astrocytes,
ences suggest that in different cells these molecules
APC selectively accumulates at the leading edge [21].
might orchestrate differently in their control of cell po-
Moreover, APC directly interacts with KAP3 [22]. The
larity.
complex formation of APC/KAP3/KIF3 suggests that
APC is involved in directing the transport of cargos asso- Supplemental Data
ciated with KIF3 motors along microtubules to the ac- Supplemental Data including Experimental Procedures and four ad-
ditional figures are available at http://www.current-biology.com/cgi/tively growing region of the cell, such as the leading
content/full/14/22/2025/DC1/.edge of a migrating epithelial cell or astrocyte, where
APC selectively accumulates. When a hippocampal neu-
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